Skip to main content

Table 2 Clinical findings

From: The clinical features and estimated incidence of MIS-C in Cape Town, South Africa

Signs and Symptoms

Count (%)

n = 68a

Laboratory findings (normal range)

Median n = 68a

N abnormal (%)

Fever

68 (100)

Minimum

Sodium (136–145 mmol/L)

b129 (127, 131)

67 (98)

Tachycardia

67 (98.5)

Platelets (180–440 × 109/L)

189 (134, 275)

32 (47)

Rash

58 (85.3)

Hb (11.8–14.6 g/dL)

b9.7 (8.4, 10.8)

60 (88)

Conjunctivitis

53 (77.9)

Albumin (29–42 g/L)

27 (25, 30) n = 63

44 (70)

Abdominal pain

41 (60.3)

Lymphocyte count (1.90–4.30 × 109/L)

1.16 (0.75, 2.28) n = 67

44 (66)

Hypotension

41 (60.3)

Maximum

CRP (< 10 mg/L)

b242 (140, 308) n = 67

67(100)

Diarrhoea

40 (58.8)

Troponin-T (< = 14 ng/L)

b38 (16, 72) n = 45

34 (75)

Mucositis

19/41 (46.3)

pro-BNP (< 450 ng/L)

b5785 (737, 19,898) n = 62

50 (81)

Arthritis

19 (27.9)

Neutrophil count (1.7–5.0 × 109/L)

b11.99 (7.30, 18.49) n = 67

59 (88)

Headache

18 (26.4)

WCC (3.90–10.20 × 109/L)

b16.60 (12.54, 24.74)

57 (84)

Organ Involvement

 

Ferritin (7–84 ng/L)

b643 (317, 1022) n = 65

64 (98)

 Lung

20 (29.4)

D-dimer (0.00–0.25 mg/L)

b2.60 (1.29, 4.91) n = 59

58 (98)

 CNS

19 (27.9)

Fibrinogen (2.0–4.0 g/L)

b5.3 (4.5, 6.4) n = 57

48 (84)

 Renal

19 (27.9)

Urea (1.4–5.7 mmol/L)

6.8 (4.2, 12.7)

40 (59)

Cardiac

 

Creatinine (30–48 umol/L)

47 (35, 76)

33 (49)

 Mitral regurgitation

25 (36.8)

AST (0–41 U/L)

46 (31, 61) n = 61

34 (73)

 Pericardial effusion

12 (17.6)

ALT (5–25 U/L)

33 (22, 55) n = 64

44 (69)

 Coronary artery aneurysm

4 (5.9)

Maximum LDH (110–295 U/L)

325 (279, 419) n = 25

15 (60)

  1. CNS Central nervous system, CRP C-reactive protein, Hb haemoglobin, WCC white cell count, ALT alanine transaminase, AST aspartamine transaminase, pro-BNP Pro-beta natriuretic protein, LDH lactate dehydrogenase
  2. an = 68 unless specified
  3. bInterquartile range of median estimate is outside of normal range of laboratory test